Key stats
About LS ARK GENOMIC REVOLUTION TRACKER ETP
Expense ratio
0.35%
Home page
Inception date
Dec 14, 2021
ISIN
XS2399368062
The objective of the LS ARKG Genomic Tracker ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the Reference Asset),
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
ETF
Bonds, Cash & Other100.00%
ETF100.00%
Cash−0.00%
Stock breakdown by region
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history